Combined with the fact that FLT3-mutant AML, especially with NPM1 co-mutation, tend to have myelomonocytic differentiation (FAB M5), these patients are at high risk of leukostasis and multi organ failure. The gene discussed is FLT3; the disease is acute myeloid leukemia.